Minireviews
Copyright ©2014 Baishideng Publishing Group Co.
World J Orthop. Jan 18, 2014; 5(1): 30-37
Published online Jan 18, 2014. doi: 10.5312/wjo.v5.i1.30
Table 1 Clinical studies of demineralized bone matrix used in spinal fusion
Ref.Study designDiagnosis/proceduresType of graftMain outcomesLevel of evidence
Cervical spine
An et al[48]2-Center randomized prospective control trialPatients undergone anterior cervical fusion for degenerative disc disease, n = 77Freeze-dried allograft augmented with DBM (Grafton®), n = 39. Iliac Crest Autograft, n = 38Pseudarthrosis rate was 46.2% in DBM-allograft Group vs 26.3% in autograft group, but with no significant differences. Graft collapse ≥ 2 mm occurred in 39.7% in DBM-allograft group than 24.4% in autograft group (P = 0.09)II
Vaidya et al[49]Retrospective comparative studyPatients treated with anterior cervical discectomy and fusion, n = 46PEEK cages + morphogenetic protein-2 (rhBMP-2), n = 22 Allograft spacers + DBM, n = 24No significant difference in pain scores between groups. Probable fusion at latest follow up in 23/24 of DBM group vs 22/22 in rhBMP-2 group. 85% of rhBMP-2 and 56% of DBM reported difficulty in swallowing. The cost of implants in patients treated with rhBMP-2 and PEEK spacers was more than three times the cost of the other groupIII
Park et al[52]Prospective, case series studyPatients undergoing anterior cervical discectomy and fusionPEEK cages and DBM (Grafton®), n = 3197% fusion rate (41/42 levels), neck and arm pain improved after surgery and significanly improved in 12/12 follow-up, P < 0.05IV
Topuz et al[50]Retrospective, case series studyPatients underwent 2-level contiguousanterior cervical discectomy and fusionPEEK cages and DBM (Grafton®) and autologous blood, n = 7987.3% "excellent" and "good" clinical outcomes, final fusion rate 91.7% (145/158 levels)IV
Moon et al[51]Retrospective case seriesPatients undergone 2-level, non-instrumented cervical fusion for degenerative disk disease, n = 27 (54 levels)PEEK cages and DBMFusion rate was 88.9% of levels. All patients showed improvements in clinical outcomes (VAS score, neurologic pain and JOA myelopathy score)IV
Demircan et al[53]Prospective case seriesPatients undergone non-instrumented anterior cervical fusion for degenerative disk disease, n = 16 (42 levels)Polyetheretherketone cages packed with autologous blood, curettage microchip material, and DBM (Grafton®)Fusion rate was 90.5% of levels, at 18 mo after surgery with improved clinical outcomes using JOA score (P = 0.004)IV
Lumbar spine
Kang et al[54]Prospective multicenter randomized clinical trailPatients undergoing single-level posterior lumbar fusionDBM (Grafton®) + local bone, n = 30. Autologous iliac crest bone graft, n = 16Fusion rates were 86% (Grafton®) vs 92% (autologous graft). Grafton showed consistently higher physical function scores at 24 mo. There was a greater mean intraoperative blood loss in the autologous group.I
Cammisa et al[3]Prospective multicenter control trialPatients undergone posterolateral lumbar, instrumented fusion, n = 120Iliac Crest Autograft on one side DBM (Grafton®) + Iliac crest autograft on contralateral side of same patientRadiographic fusion rates at 24 mo after surgery in Grafton DBM side was 52% and in Iliac Crest Bone Autograft side was 54%II
Vaccaro et al[55]Prospective, comparative studyPatients undergone instrumented posterolateral lumbosacral spinal fusionDBM (Grafton®) + Bone Marrow, n = 19, DBM + Iliac crest autograft, n = 27 Autograft, n = 27Fusion rates were 63% with DBM + Bone Marrow, 70% DBM + autograft and 67% with autograftIII
Sassard et al[56]Retrospective comparative studyInstrumented posterolateral lumbar spinal fusion with rigid pedicle screw fixation (n = 108)Iliac crest bone graft (n = 52). Local autograft-Grafton® (n = 56)Fusion rates at 24 mo after surgery: In Iliac crest bone graft group: 56% and in local autograft-Grafton group: 60%III
Schizas et al[57]Retrospective case control studyPatients undergone posterolateral, one or two-level, instrumented, lumbar fusion, n = 59 (78 levels)DBM (Accell Connexus® putty) with Iliac crest autograft or local decompression material, n = 33. Iliac crest autograft or local decompression material, n = 26Fusion rate was 69.7% with DBM vs 76.9% without DBM. There were no differences in complication rates, ODI or VAS pain scoreIII
Epstein et al[58]Prospective, clinical studyPatients undergone multilevel lumbar laminectomies, 1-level (n = 95) and 2-levels (n = 45)Lamina autograft + DBM (Osteofil), n = 1401-level fusion rates: 98%, 2-levels fusion rates: 96%. Revealed essentially comparable outcomes on 6 of 8 Health Scales of SF-36IV
Thalgott et al[61]Prospective case series studyPatients undergone lumbar interbody fusion (n = 50)Titanium mesh cages filled with coralline hydroxyapatite (ProOsteon™ 500R) and DBM (Grafton®)96% fusion rate, decrease in mean pain scores by 60% from baselineIV
Girardi et al[60]Retrospective case series studyInstrumented lumbar spinal fusion for various diagnoses (n = 65)Combination of autologous bone graft and allograft DBM (AlloMatrix® Injectable Putty)Gradual and constant improvement based on radiographic measurements taken 1, 3, 6 and 12 mo after surgeryIV
Thalgott et al[62]Retrospective case seriesPatients undergone instrumented posterolateral lumbar fusion, n = 40Coralline hydroxyapatite (Pro Osteon™ 500) + DBM (Grafton®), n = 28 Pro Osteon™ 500 alone, n = 12Radiographic fusion rates was 100% with coralline hydroxyapatite alone, than 89.3% with Grafton added.IV
Epstein[59]Prospective case seriesGeriatric patients undergone posterolateral non-instrumented lumbar fusion, n = 75Lamina autograft mixed with DBM (Osteofil) in 1:1 ratioFusion rate was 82.7% of levels. Improved clinical outcomes using SF-36 score.IV
Idiopathic scoliosis
Weinzapfel et al[63]Retrospective comparative studyAnterior thoracic discectomies with video Assisted thoracoscopic surgery in idiopathic scoliosisMorselized allograft bone, n = 12. DBM (Grafton®), n = 28Curve correction was similar for both groups (68% vs 67%). Radiological fusion fusion: 82% in allograft group vs 92% in DBM groupIII